Autophagy, cancer stem cells, and trastuzumab resistance in three dimensional cultures of HER2+breast cancer cells

被引：0
|
作者：
Rodriguez, Cristina E. [1 ]
Reidel, Sara [2 ]
Adela Jasnis, Maria [1 ]
Bal de Kier Joffe, Elisa [1 ]
Fiszman, Gabriel L. [2 ]
机构：
[1] Univ Buenos Aires, Inst Oncol AH Roffo, Buenos Aires, DF, Argentina
[2] Natl Inst Ind Technol, Ctr Ind Biotechnol, Buenos Aires, DF, Argentina
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-349
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
349
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Involvement of microRNA-146a in trastuzumab resistance of HER2+breast cancer cells
    Cabello, P.
    Fores, J.
    Tormo, E.
    Pineda, B.
    Adam, A.
    Garrido, I.
    Pattanayak, B.
    Lluch, A.
    Eroles, P.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [2] Transcriptome and chromatin landscape changes associated with trastuzumab resistance in HER2+breast cancer cells
    Murad, Rabi
    Avanes, Arabo
    Ma, Xinyi
    Geng, Shuhui
    Mortazavi, Ali
    Momand, Jamil
    [J]. GENE, 2021, 799
  • [3] Visualizing trastuzumab-deruxtecan action in HER2+breast cancer cells at nanoscale
    Cortese, K.
    Garrone, O.
    Gagliani, M. C.
    Bellese, G.
    Arnaldi, P.
    Abbona, A.
    Paccagnella, M.
    Ruatta, F.
    Merlano, M. C.
    Castagnola, P.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S197 - S197
  • [4] Inhibiting telomerase to reverse trastuzumab (T) resistance in HER2+breast cancer
    Miller, K. D.
    Steding, C. E.
    Prasad, N.
    Rojas, L. A.
    Herbert, B-S
    [J]. CANCER RESEARCH, 2012, 72
  • [5] Delineating the mechanisms of resistance to panHER inhibitors in HER2+breast cancer cells
    Kutuk, O.
    Basaga, H.
    Ozmay, Y.
    Karakas, B.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [6] Molecular Atlas of HER2+Breast Cancer Cells Treated with Endogenous Ligands: Temporal Insights into Mechanisms of Trastuzumab Resistance
    Mukund, Kavitha
    Alva-Ornelas, Jackelyn A.
    Maddox, Adam L.
    Murali, Divya
    Veraksa, Darya
    Saftics, Andras
    Tomsic, Jerneja
    Frankhouser, David
    Razo, Meagan
    Jovanovic-Talisman, Tijana
    Seewaldt, Victoria L.
    Subramaniam, Shankar
    [J]. CANCERS, 2024, 16 (03)
  • [7] Antitumor properties of bromelain loaded trastuzumab conjugated niosomes in HER2+breast cancer cells
    Tut, Ezgi
    Guldu, Ozge Kozgus
    Medine, Emin Ilker
    [J]. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2024, 101
  • [8] Safety of trastuzumab in women with HER2+breast cancer.
    Nowsheen, Somaira
    Aziz, Khaled
    Park, Jae Yoon
    Villarraga, Hector R.
    Herrmann, Joerg
    Ruddy, Kathryn Jean
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] TRASTUZUMAB INDUCED CARDIOTOXICITY IN PATIENTS WITH HER2+BREAST CANCER
    Santamaria Elena, Capilla
    Garcia Beatriz, Benitez
    Jose Antonio, Romero Garrido
    Aunon Pilar, Zamora
    Abad Gema, Casado
    del Valle Luis, Gonzalez
    Ambrosio Alicia, Herrero
    [J]. ATENCION FARMACEUTICA, 2013, 15 (04): : 261 - 267
  • [10] STAT6 expression and trastuzumab resistance in HER2+breast cancer.
    Cobleigh, Melody A.
    DiScala, Molly
    Najor, Matthew S.
    Yung, Timothy
    Abukhdeir, Abde M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345